Harrow (HROW) EBT (QoQ) (2010 - 2026)
Harrow (HROW) EBT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Harrow | 1.58 Bn | 1.49 Bn | 50.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.38% |
| Mar 31, 2026 | -365.24% |
| Dec 31, 2025 | 919.31% |
| Sep 30, 2025 | -79.58% |
| Jun 30, 2025 | 128.09% |
| Mar 31, 2025 | -383.89% |
| Dec 31, 2024 | 249.12% |
| Sep 30, 2024 | 27.81% |
| Jun 30, 2024 | 57.11% |
| Mar 31, 2024 | -40.09% |
| Dec 31, 2023 | -239.52% |
| Sep 30, 2023 | 32.80% |
| Jun 30, 2023 | 38.77% |
| Mar 31, 2023 | -756.97% |
| Dec 31, 2022 | 116.41% |
| Sep 30, 2022 | -3.71% |
| Jun 30, 2022 | -154.27% |
| Mar 31, 2022 | 66.53% |
| Dec 31, 2021 | 12.52% |
| Sep 30, 2021 | -236.08% |